Emerg Infect Dis by Moss, William J. et al.
Emerging Infectious Diseases  •  Vol. 9, No. 2, February 2003 273
LETTERS
In summary, the occurrence of St.
Louis encephalitis in a 61-year-old
patient, after >10 years of no reports
in Argentina, along with specific epi-
demiology, suggest that further studies
are needed to assess the risk for
human infection by SLEV in Argen-
tina and the role of several mosquito
species in its transmission.
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To the Editor: Carey et al.
recently reported in this journal a case
of catheter-related bacteremia attrib-
uted to Streptomyces in a patient
receiving holistic infusions (1). We
describe the isolation of Streptomyces
bikiniensis from multiple blood cul-
tures in a single patient over the
course of 1 week, further illustrating
that Streptomyces is pathogenic and a
cause of bacteremia even in the
absence of overt clinical symptoms
and risk factors.
A 14-year-old girl with osteosar-
coma of the right proximal tibia came
to our hospital 13 months after diag-
nosis for her final course of chemo-
therapy. At the time of diagnosis, a
double-lumen central venous catheter
was inserted. Her course was compli-
cated by poor response to chemother-
apy, and a limb salvage procedure was
performed 3 months after diagnosis.
The proximal tibia was replaced with
a cadaveric bone graft. Several hours
after the patient received methotrex-
ate, a fever of 39.2°C developed. No
sign of infection was observed on
physical examination. Her leukocyte
count was 6,300 cells/mm3 with an
absolute neutrophil count of 4,914
cells/mm3. She received a single dose
of acetaminophen and was without
fever for the remainder of her hospi-
talization. A blood culture obtained
from the central venous catheter at the
time of fever grew Streptomyces.
Repeat blood cultures obtained from
both ports of the central venous cathe-
ter on day 3 and a peripheral blood
culture obtained on day 4 also grew
Streptomyces. Treatment with vanco-
mycin and cotrimoxazole was started
on day 4 in the hospital. The Strepto-
myces isolate was susceptible to van-
comycin, amikacin, cotrimoxazole,
erythromycin, cephazolin, and tetracy-
cline and was resistant to ampicillin,
penicillin, oxacillin, and clindamycin.
A blood culture drawn from the cen-
tral venous catheter on day 3 of antibi-
otic therapy (the 6th day in the
hospital) grew Streptomyces after 9
days of incubation. All subsequent
blood cultures were without growth.
The central venous catheter was
removed, and the patient received van-
comycin intravenously for 6 weeks,
without recurrence of Streptomyces
bacteremia.
The bone graft was considered a
potential source of infection. As most
cases of disease from Streptomyces
occur in the tropics, we requested
information on whether the donor
traveled or resided outside the United
States. However, the donor had no his-
tory of travel outside the United
States. All cultures taken from the
donor and the graft were without
growth (although this did not exclude
the graft as the source of infection),
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and no reports of disease transmission
were received from any other recipi-
ents of organs from this donor. In
addition, the patient had no history of
receiving infusions of holistic or alter-
native medicines.
The organism was initially
detected in the aerobic Bact/Alert
blood culture system (bioMérieux,
Inc., Durham, NC) after 72 h incuba-
tion at 35°C. Presumptive identifica-
tion of the pleomorphic gram-positive
bacillus as Streptomyces sp. was based
on phenotypic characterization by
using standard conventional tests and
cellular fatty acid analysis. Species
identification was determined by
DNA sequencing of the 16S rRNA
gene. DNA sequencing reactions were
performed with the Tag Dye Deoxy
Terminator Cycle Sequencing Kit
(Applied Biosystems, Inc., Foster
City, CA), and data were generated
with an ABI 377 automated instru-
ment. The sequence data were assem-
bled, edited, and compared with
published sequences for the 16S
rRNA gene of S. bikiniensis (2).
The genus Streptomyces belongs to
the order Actinomycetales, which
includes Mycobacterium, Nocardia,
and Actinomyces. Streptomyces are
gram-positive, extensively branched,
filamentous bacteria that form aerial
hyphae with chains of spores. Their
natural habitat is soil, and each species
has a defined geographic distribution.
None are common in the United
States. With the exception of speci-
mens from actinomycotic mycetoma,
the isolation of Streptomyces from
clinical specimens frequently is con-
sidered laboratory contamination (3).
Rare cases of clinical disease attrib-
uted to Streptomyces have been pub-
lished, including bloodstream
infection (1,4) and focal invasive
infections (5–9). Streptomyces was not
the only potential pathogen isolated
from some of the clinical specimens in
these studies. 
Scant data are available on effec-
tive treatment of Streptomyces infec-
tion. Mycetoma caused by Strep-
tomyces is often treated with penicillin,
sulfonamides, or tetracycline; how-
ever, the cure rate is low. The recom-
mended duration of therapy is lengthy
(up to 10 months). Isolates of S. gri-
seus referred to the Centers for Disease
Control and Prevention were fre-
quently resistant to ampicillin (80%),
sulfamethoxazole (43%), cotrimox-
azole (29%), and ciprofloxacin (57%)
(10). Resistance to doxycycline (19%)
and minocycline (10%) was lower.
Vancomycin susceptibility was not
tested. Resistance patterns must be
interpreted cautiously because Strepto-
myces can synthesize antibiotics,
potentially confounding results of in-
vitro susceptibility testing. 
The patient described in this report
had no signs or symptoms of infection.
The transient fever that prompted the
first blood culture was probably due to
the methotrexate infusion and not
infection with S. bikiniensis. That the
fever was of short duration despite
persistently positive blood cultures
supports this conclusion. The potential
for causing minimal symptoms may
contribute to assignment of Streptomy-
ces as a contaminant. Clinical correla-
tion is difficult if the infection is
silent. Streptomyces isolated from
blood cultures should not be dismissed
as contaminants without careful con-
sideration of the clinical situation; the
isolation of Streptomyces from repeat
blood cultures strongly suggests a
pathogenic role. 
William J. Moss,* Jason A. Sager,* 
James D. Dick,* and Andrea Ruff* 
*Johns Hopkins University, Baltimore,
Maryland
References
  1. Carey J, Motyl M, Perlman DC. Catheter-
related bacteremia due to Streptomyces in a
patient receiving holistic infusions. Emerg
Infect Dis 2001;7:1043–5.
  2. Maidak BL, Cole JR, Parker CT Jr, Garrity
GM, Larsen N, Li B, et al. A new version
of the RDP (Ribosomal Database Project).
Nucleic Acids Res 1999;27:171–3.
  3. McNeil MM, Brown JM. The medically
important aerobic actinomycetes: epidemi-
ology and microbiology. Clin Microbiol
Rev 1994;7:357–417.
  4. Kohn PM, Tager M, Siegel ML, Ashe R.
Aerobic Actinomyces septicemia. N Engl J
Med 1951;245:640–4.
  5. Clarke PRP, Warnock GBR, Blowers R,
Wilkinson M. Brain abscess due to Strepto-
myces griseus. J Neurol Neurosurg Psychi-
atry 1964;27:553–5.
  6. Cantwell AR Jr, Craggs E, Swatek F, Wil-
son JW. Unusual acid-fast bacteria in pan-
niculitis. Arch Dermatol 1966;94:161–7.
  7. Shanley JD, Snyder K, Child JS. Chronic
pericarditis due to a Streptomyces species.
Am J Clin Pathol 1979;72:107–10.
  8. Mossad SB, Tomford JW, Stewart R, Rat-
liff NB, Hall GS. Case report of Streptomy-
ces endocarditis of a prosthetic aortic
valve. J Clin Microbiol 1995;33:3335–7.
  9. Dunne EF, Burman WJ, Wilson MJ. Strep-
tomyces pneumonia in a patient with the
human immunodeficiency virus infection:
case report and review of the literature on
invasive Streptomyces infectious. Clin
Infect Dis 1998;27:93–6.
10. McNeil MM, Brown JM, Jarvis WR, Ajello
L. Comparison of species distribution and
antimicrobial susceptibility of aerobic acti-
nomycetes from clinical specimens. Rev
Infect Dis 1990;12:778–83.
Address for correspondence: William J. Moss,
Department of International Health, 615 North








To the Editor: Spread of drug-
resistant tuberculosis (TB) and disas-
trous rates of HIV-TB co-infection
pose serious threats to TB-control pro-
grams around the world (1). The
World Health Organization/Interna-
tional Union Against Tuberculosis and
Lung Diseases urges all national TB
programs to practice the Directly
Observed Treatment-Short Course
(DOTS) strategy as well as to closely
monitor the patterns and trends of
anti-TB drug resistance (2). Such data
allow an assessment of the quality of
TB control, help forecast future trends
